OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study
Mijin Kim, Meihua Jin, Min Ji Jeon, et al.
Thyroid (2022) Vol. 33, Iss. 1, pp. 91-99
Closed Access | Times Cited: 32
Mijin Kim, Meihua Jin, Min Ji Jeon, et al.
Thyroid (2022) Vol. 33, Iss. 1, pp. 91-99
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Thyroid cancer
Debbie Chen, Brian Hung‐Hin Lang, Donald S.A. McLeod, et al.
The Lancet (2023) Vol. 401, Iss. 10387, pp. 1531-1544
Closed Access | Times Cited: 269
Debbie Chen, Brian Hung‐Hin Lang, Donald S.A. McLeod, et al.
The Lancet (2023) Vol. 401, Iss. 10387, pp. 1531-1544
Closed Access | Times Cited: 269
Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition)
Yansong Lin, Renfei Wang, Rui Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access | Times Cited: 1
Yansong Lin, Renfei Wang, Rui Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access | Times Cited: 1
An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer
Karen Yun, Ezra E.W. Cohen
JCO Oncology Practice (2024) Vol. 20, Iss. 7, pp. 899-906
Closed Access | Times Cited: 4
Karen Yun, Ezra E.W. Cohen
JCO Oncology Practice (2024) Vol. 20, Iss. 7, pp. 899-906
Closed Access | Times Cited: 4
Advances in Diagnosis and Treatment of Radioactive Iodine Refractory Differentiated Thyroid Cancer
Yongji Jiang, Chao Ma, Renfei Wang, et al.
IntechOpen eBooks (2025)
Closed Access
Yongji Jiang, Chao Ma, Renfei Wang, et al.
IntechOpen eBooks (2025)
Closed Access
Thyroid cancer: Current status of preclinical landscape
E Nyarko, Emmanuel Ofori
Elsevier eBooks (2025), pp. 115-138
Closed Access
E Nyarko, Emmanuel Ofori
Elsevier eBooks (2025), pp. 115-138
Closed Access
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life
Vincenzo Marotta, Domenico Rocco, Anna Crocco, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 10, pp. 2541-2552
Open Access | Times Cited: 3
Vincenzo Marotta, Domenico Rocco, Anna Crocco, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 10, pp. 2541-2552
Open Access | Times Cited: 3
Sorafenib versus Lenvatinib Causes Stronger Oxidative Damage to Membrane Lipids in Noncancerous Tissues of the Thyroid, Liver, and Kidney: Effective Protection by Melatonin and Indole-3-Propionic Acid
Jan Stępniak, Joanna Krawczyk-Lipiec, Andrzej Lewiński, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2890-2890
Open Access | Times Cited: 11
Jan Stępniak, Joanna Krawczyk-Lipiec, Andrzej Lewiński, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2890-2890
Open Access | Times Cited: 11
Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor‐targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer
Taigo Kato, Ryuichi Mizuno, Hideaki Miyake
International Journal of Urology (2024) Vol. 31, Iss. 5, pp. 465-474
Open Access | Times Cited: 2
Taigo Kato, Ryuichi Mizuno, Hideaki Miyake
International Journal of Urology (2024) Vol. 31, Iss. 5, pp. 465-474
Open Access | Times Cited: 2
Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma
Iram S. Alam, Kepal N. Patel
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 751-765
Closed Access | Times Cited: 2
Iram S. Alam, Kepal N. Patel
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 751-765
Closed Access | Times Cited: 2
Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
João Roque, Tiago Silva, Catarina Regala, et al.
European Thyroid Journal (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 4
João Roque, Tiago Silva, Catarina Regala, et al.
European Thyroid Journal (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 4
Progranulin promoted the proliferation, metastasis, and suppressed apoptosis via JAK2-STAT3/4 signaling pathway in papillary thyroid carcinoma
Yanxu Dong, Hao Tan, Lidong Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Yanxu Dong, Hao Tan, Lidong Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States
Francis P. Worden, Olivera Rajkovic‐Hooley, Neil A Reynolds, et al.
Endocrine (2023) Vol. 84, Iss. 2, pp. 663-669
Open Access | Times Cited: 4
Francis P. Worden, Olivera Rajkovic‐Hooley, Neil A Reynolds, et al.
Endocrine (2023) Vol. 84, Iss. 2, pp. 663-669
Open Access | Times Cited: 4
Response to sorafenib in a locally advanced oncocytic cell carcinoma of the thyroid
Andrés Pereira, Diana C. Parra, Mauricio Álvarez, et al.
BMJ Case Reports (2024) Vol. 17, Iss. 2, pp. e257738-e257738
Closed Access | Times Cited: 1
Andrés Pereira, Diana C. Parra, Mauricio Álvarez, et al.
BMJ Case Reports (2024) Vol. 17, Iss. 2, pp. e257738-e257738
Closed Access | Times Cited: 1
Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib
Chae A Kim, Mijin Kim, Meihua Jin, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 334-343
Open Access | Times Cited: 1
Chae A Kim, Mijin Kim, Meihua Jin, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 334-343
Open Access | Times Cited: 1
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
Valentina Cirello, Carla Gambale, Alyaksandr V. Nikitski, et al.
Panminerva Medica (2024) Vol. 66, Iss. 2
Open Access | Times Cited: 1
Valentina Cirello, Carla Gambale, Alyaksandr V. Nikitski, et al.
Panminerva Medica (2024) Vol. 66, Iss. 2
Open Access | Times Cited: 1
Ten years’ real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer
Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 817-826
Open Access | Times Cited: 1
Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 817-826
Open Access | Times Cited: 1
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 4. Systemic Therapy for Progressive Radioiodine-Refractory Differentiated Thyroid Cancer 2024
Dong Yeob Shin, Ho‐Cheol Kang, Sun Wook Kim, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 168-181
Open Access | Times Cited: 1
Dong Yeob Shin, Ho‐Cheol Kang, Sun Wook Kim, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 168-181
Open Access | Times Cited: 1
Schilddrüsenkarzinome – Rolle internistischer Systemtherapien
Tim Brandenburg, Matthias Kroiß
Deleted Journal (2024) Vol. 65, Iss. 7, pp. 642-655
Closed Access | Times Cited: 1
Tim Brandenburg, Matthias Kroiß
Deleted Journal (2024) Vol. 65, Iss. 7, pp. 642-655
Closed Access | Times Cited: 1
Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer
Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1
Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis
Yuhang Xue, Yuzhe Zhang, Xintao Ding, et al.
Annals of Nuclear Medicine (2024)
Open Access | Times Cited: 1
Yuhang Xue, Yuzhe Zhang, Xintao Ding, et al.
Annals of Nuclear Medicine (2024)
Open Access | Times Cited: 1
Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer
Mariana Teixeira Rodrigues, Ana Paula Picaro Michelli, Gustavo Felisola Caso, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1687-1687
Open Access | Times Cited: 2
Mariana Teixeira Rodrigues, Ana Paula Picaro Michelli, Gustavo Felisola Caso, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1687-1687
Open Access | Times Cited: 2
RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M. Kowalski, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5298-5298
Open Access | Times Cited: 3
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M. Kowalski, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5298-5298
Open Access | Times Cited: 3
Ten Years’ Real-Life Experience on the Use of Multikinase Inhibitors in Patients with Advanced Differentiated Thyroid Cancer
Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Research Square (Research Square) (2024)
Open Access
Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Research Square (Research Square) (2024)
Open Access
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 10, pp. 1435-1443
Closed Access
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 10, pp. 1435-1443
Closed Access
Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements
Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, et al.
Thyroid Research (2024) Vol. 17, Iss. 1
Open Access
Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, et al.
Thyroid Research (2024) Vol. 17, Iss. 1
Open Access
